Article
CLL biology and prognosis.
Hematology. American Society of Hematology. Education Program - 1 Jan 2005
Dighiero Guillaume
Abstract excerpt
Chronic lymphocytic leukemia (CLL) follows an extremely variable course with survival ranging from months to decades. Recently, there has been major progress in the identification of molecular and cellular markers that may predict the tendency for disease progression in CLL patients. In particular, the mutational profile of Ig genes and some cytogenetic abnormalities have been found to be important predictors of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
